Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Fund Letter | The Heartland Investment TeamHeartland Value Fund | Patterson Companies, Inc. $PDCO• NASDAQ | -- | Long PDCO (Patterson Companies, Inc.) Patterson Companies was significantly undervalued by the market, particularly given its $4 billion animal health division. Trading at half... | BULL | View Pitch → |
| Jan 8, 2026 | Fund Letter | Chip ReweyRewey Asset Management | Aerospace & DefenseAerospace & Defense | Rewey Asset Management 2025 Q2 (DCO) Ducommun, highlighted in our 1Q25 letter, was our top performer in 2Q25, rising 42.39%. Our thesis on... | BULL | View Pitch → | |
| Dec 4, 2025 | Fund Letter | Aaron MonroeDiamond Hill Small Cap Fund | Aerospace & DefenseAerospace & Defense | Diamond Hill Small Cap Fund 2025 Q2 (DCO) Ducommun is a critical Tier 1 and Tier 2 supplier of advanced material aerostructures and electrical components to the defense and commercial markets. Shares rose in... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.